Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye

• Status: Completed
• Trial end date: 2007-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to see if Rimexolone (FID 109980) is a safe and effective treatment of dry eye.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Rimexolone

Criteria

Inclusion Criteria:

• documented dry eye history

• ocular symptoms

• tear use

• dry eye ocular signs

Exclusion Criteria:

• Under 18